Management of acute severe ulcerative colitis in Spain: A nationwide clinical practice survey

Ungaro, 2017, Ulcerative colitis, Lancet, 389, 1756, 10.1016/S0140-6736(16)32126-2 Bitton, 2012, Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements, Am J Gastroenterol, 107, 179, 10.1038/ajg.2011.386 Truelove, 1955, Cortisone in ulcerative colitis; final report on a therapeutic trial, Br Med J, 2, 1041, 10.1136/bmj.2.4947.1041 Lynch, 2013, Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit, Aliment Pharmacol Ther, 38, 935, 10.1111/apt.12473 Turner, 2007, Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression, Clin Gastroenterol Hepatol, 5, 103, 10.1016/j.cgh.2006.09.033 Harbord, 2017, Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management, J Crohns Colitis, 11, 769, 10.1093/ecco-jcc/jjx009 Gisbert, 2018, Acute severe ulcerative colitis: state of the art treatment, Best Pract Res Clin Gastroenterol, 32–33, 59, 10.1016/j.bpg.2018.05.007 Gomollon, 2013, Therapeutic guidelines on ulcerative colitis: a GRADE methodology based effort of GETECCU, Gastroenterol Hepatol, 36, 104, 10.1016/j.gastrohep.2012.09.006 Harris, 2009, Research electronic data capture (REDCap) — a metadata-driven methodology and workflow process for providing translational research informatics support, J Biomed Inform, 42, 377, 10.1016/j.jbi.2008.08.010 Fumery, 2018, Natural history of adult ulcerative colitis in population-based cohorts: a systematic review, Clin Gastroenterol Hepatol, 16, 10.1016/j.cgh.2017.06.016 Herfarth, 2015, Pushing the pedal to the metal: should we accelerate infliximab therapy for patients with severe ulcerative colitis?, Clin Gastroenterol Hepatol, 13, 336, 10.1016/j.cgh.2014.09.045 Siegmund, 2017, Cytomegalovirus infection associated with inflammatory bowel disease, Lancet Gastroenterol Hepatol, 2, 369, 10.1016/S2468-1253(16)30159-5 Kopylov, 2017, Impact of infliximab and cyclosporine on the risk of colectomy in hospitalized patients with ulcerative colitis complicated by cytomegalovirus — a multicenter retrospective study, Inflamm Bowel Dis, 23, 1605, 10.1097/MIB.0000000000001160 Hindryckx, 2017, Review article: dose optimisation of infliximab for acute severe ulcerative colitis, Aliment Pharmacol Ther, 45, 617, 10.1111/apt.13913 Brandse, 2015, Loss of infliximab into feces is associated with lack of response to therapy in patients with severe ulcerative colitis, Gastroenterology, 149, 10.1053/j.gastro.2015.04.016 Rosen, 2015, Review article: applying pharmacokinetics to optimise dosing of anti-TNF biologics in acute severe ulcerative colitis, Aliment Pharmacol Ther, 41, 1094, 10.1111/apt.13175 Kevans, 2018, Accelerated clearance of infliximab is associated with treatment failure in patients with corticosteroid-refractory acute ulcerative colitis, J Crohns Colitis, 12, 662, 10.1093/ecco-jcc/jjy028 Gibson, 2015, An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis, Clin Gastroenterol Hepatol, 13, 10.1016/j.cgh.2014.07.041 Choy, 2016, Mo1878 Comparison of accelerated infliximab induction vs standard induction treatment in acute severe ulcerative colitis, Gastroenterology, 150, S803, 10.1016/S0016-5085(16)32720-2 Narula, 2015, Systematic review: sequential rescue therapy in severe ulcerative colitis: do the benefits outweigh the risks?, Inflamm Bowel Dis, 21, 1683, 10.1097/MIB.0000000000000350 Ordás, 2018, Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: nationwide multicenter study of the GETECCU ENEIDA Registry, Am J Gastroenterol, 113, 1009, 10.1038/s41395-018-0057-0